"Red-Cell Aplasia, Pure" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.
| Descriptor ID |
D012010
|
| MeSH Number(s) |
C15.378.071.750
|
| Concept/Terms |
Red-Cell Aplasia, Pure- Red-Cell Aplasia, Pure
- Red Cell Aplasia, Pure
- Erythrocyte Aplasia
- Aplasia, Erythrocyte
- Aplasias, Erythrocyte
- Erythrocyte Aplasias
- Pure Red-Cell Aplasia
- Aplasia, Pure Red-Cell
- Aplasias, Pure Red-Cell
- Pure Red Cell Aplasia
- Pure Red-Cell Aplasias
- Red-Cell Aplasias, Pure
|
Below are MeSH descriptors whose meaning is more general than "Red-Cell Aplasia, Pure".
Below are MeSH descriptors whose meaning is more specific than "Red-Cell Aplasia, Pure".
This graph shows the total number of publications written about "Red-Cell Aplasia, Pure" by people in this website by year, and whether "Red-Cell Aplasia, Pure" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Red-Cell Aplasia, Pure" by people in Profiles.
-
Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2019 Jun; 12(2):115-118.
-
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia. Biol Blood Marrow Transplant. 2016 May; 22(5):961-5.
-
Thymoma complicated by acquired amegakaryocytic thrombocytopenia and pure red cell aplasia. J Natl Compr Canc Netw. 2014 Nov; 12(11):1505-9.
-
Risk of pure red cell aplasia in patients with hepatitis C receiving antiviral therapy and an erythropoiesis-stimulating agent. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):341-5.
-
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation. Br J Haematol. 2013 Mar; 160(6):798-805.
-
Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion. Br J Haematol. 2007 Jul; 138(2):271-5.
-
Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors. Br J Haematol. 2007 Mar; 136(6):800-5.
-
Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation. Am J Hematol. 2004 Mar; 75(3):142-5.
-
Acquired pure red cell aplasia in a child. J Postgrad Med. 2002 Jan-Mar; 48(1):37-8.
-
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia. Leuk Lymphoma. 1999 Nov; 35(5-6):483-9.